Foresite Capital
Investment Details
Investor Type
Venture Capital
Asset Class Focus
Healthcare, Life Sciences
Stage Focus
Seed, Series A, Series B, Series C, Series D, Pre-Seed
Geographical Focus
United States
Industries Focus
- Technology
- Infrastructure
- Software
- HealthTech
- FoodTech
- Transportation
- Food and Beverage
- Life Sciences
- Healthcare Services
- Digital Health
- Medical Devices
- Diagnostics
- Medtech
- Biotechnology
- Fashion/Beauty
Investment Size:
5,000,000 to 10,000,000 USD
Investor Details Founded: 2011
Foresite Capital is a multi-stage healthcare and life sciences investment firm founded in 2011 by Jim Tananbaum. The firm is headquartered in Larkspur, California, with additional offices in West Hollywood and New York City. Foresite Capital focuses on addressing significant unmet needs in healthcare by investing in promising businesses at all stages of their life cycles. Utilizing a data science-driven approach, the firm targets companies that leverage biology and big data to transform healthcare.
The firm's investment strategy emphasizes breakthrough opportunities at the intersection of technology and biotechnology, supported by a deeply technical investment team. As of June 2024, Foresite Capital has raised six primary funds, including Fund VI, which closed in May 2024 with $900 million in capital commitments. The firm's portfolio includes notable companies such as 10x Genomics, Element Biosciences, Lyell Immunopharma, Inscripta, Relay Therapeutics, and Gemini Therapeutics.
Foresite Capital's team offers comprehensive support to its portfolio companies, leveraging expertise in company formation, therapeutics product development, and data science/machine learning to provide strategic guidance and technical assistance. The firm's mission is to catalyze the transformation of healthcare by funding innovative companies that can address critical challenges in the sector.
Requirements
- Companies leveraging biology and big data to transform healthcare
- Breakthrough opportunities at the intersection of technology and biotechnology
- Businesses at all stages of their life cycles
Contact
[Official Website Hidden]
[LinkedIn Profile Hidden]
[HQ Location Hidden]
[Email Hidden]
[Contact Number Hidden]
Portfolio Companies
- 10x Genomics
- Element Biosciences
- Lyell Immunopharma
- Inscripta
- Relay Therapeutics
- Gemini Therapeutics
- Eikon Therapeutics
- HealthVerity
- XinThera
- Theseus Pharmaceuticals
Mentioned In
-
$49.95
-
$14.95
-
$39.95
-
$24.95
-
$19.95
-
$24.95
-
$99.00
-
$299.00
Claim this Investor
Are you an official representative of Foresite Capital?
Claim this investor to update information, manage your profile, and get a verified seal.
Claim